Breaking News

Olon S.p.A. Expands Microbial GMP Capabilities

Investing in new GMP manufacturing facility in Capua, Italy

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Olon S.p.A., an active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has started the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.   “I am pleased to announce the start of this GMP capacity expansion just within 6 months after the acquisition of Capua BioServices,” said Paolo Tubertini, chief executive officer, Olon. “This truly confirms the real opportunity to ac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters